Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 9196156

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1997 Jun
First author
Burris HA 3rd

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 1998 Feb;16(2):803.
    note
    Source null
    related pmid
    9469376
    relationship
    Comment in
  2. citation
    J Clin Oncol. 1998 Feb;16(2):803-4. doi: 10.1200/JCO.1998.16.2.803.
    note
    Source null
    related pmid
    9469377
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2023 Dec 20;41(36):5482-5492. doi: 10.1200/JCO.22.02777.
    note
    Source null
    related pmid
    38100992
    relationship
    Republished in

Authors and identifiers

  1. name
    Burris HA 3rd
    type
    Author
  2. name
    Moore MJ
    type
    Author
  3. name
    Andersen J
    type
    Author
  4. name
    Green MR
    type
    Author
  5. name
    Rothenberg ML
    type
    Author
  6. name
    Modiano MR
    type
    Author
  7. name
    Cripps MC
    type
    Author
  8. name
    Portenoy RK
    type
    Author
  9. name
    Storniolo AM
    type
    Author
  10. name
    Tarassoff P
    type
    Author
  11. name
    Nelson R
    type
    Author
  12. name
    Dorr FA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Burris HA 3rd
    type
    Author
  2. name
    Moore MJ
    type
    Author
  3. name
    Andersen J
    type
    Author
  4. name
    Green MR
    type
    Author
  5. name
    Rothenberg ML
    type
    Author
  6. name
    Modiano MR
    type
    Author
  7. name
    Cripps MC
    type
    Author
  8. name
    Portenoy RK
    type
    Author
  9. name
    Storniolo AM
    type
    Author
  10. name
    Tarassoff P
    type
    Author
  11. name
    Nelson R
    type
    Author
  12. name
    Dorr FA
    type
    Author
bibliography ids
  1. nci-bib-cf5ff438c5ad4b2493f092eb
book metadata
content sha256
d5563b737012c8dafad2c28f91301517f1c84881f49853aff5caa0b850bb1ece
document type
citation
dois
  1. 10.1200/JCO.1997.15.6.2403
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:9196156
immutable id
pubmed:9196156@d5563b737012c8dafad2c28f91301517f1c84881f49853aff5caa0b850bb1ece
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
6
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2403-13
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 1998 Feb;16(2):803.
    note
    Source null
    related pmid
    9469376
    relationship
    Comment in
  2. citation
    J Clin Oncol. 1998 Feb;16(2):803-4. doi: 10.1200/JCO.1998.16.2.803.
    note
    Source null
    related pmid
    9469377
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2023 Dec 20;41(36):5482-5492. doi: 10.1200/JCO.22.02777.
    note
    Source null
    related pmid
    38100992
    relationship
    Republished in
outcomes validated
false
pmid
9196156
provenance
batch id
629590480cca3a097fa8
provider
NCBI PubMed ESummary
record sha256
a13dfb2f0ecdc6b4278da7ab59de9697115be5b5c4a0cc339a2093dafdd65f55
response sha256
0eb1cec7011436204408643f1cea7888e97d436038d0a09eaecfd9b32db84919
retrieved at
2026-09-09T23:45:26.993225+00:00
publication date
display
1997 Jun
precision
month
year
1997
publication types
  1. Clinical Trial
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/9196156/
title
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Preserved source evidence · Not medical advice